Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optison in contrast-enhanced ultrasound for carotid artery disease
NCT01394926Phase 2Terminated
- Sponsor
- GE HealthCare
- Start
- Jun 2011
- Primary completion
- Jun 2012
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of perflutren lipid microspheres in carotid artery disease, sponsored by GE HealthCare. Started Jun 2011; status: terminated.
02
Drugs
perflutren lipid microspheres
03
Conditions
carotid artery disease
Beyond the preview
Go deeper on NCT01394926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01394926.